Edition:
India

Aslan Pharmaceuticals Ltd (ASLN.OQ)

ASLN.OQ on NASDAQ Stock Exchange Global Market

1.90USD
6 Jul 2020
Change (% chg)

-- (--)
Prev Close
$1.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
29,675
52-wk High
$8.18
52-wk Low
$0.35

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2020 Mar '20 0.00 -0.485
FY 2019 Dec '19 0.00 -5.379
Sep '19 0.00 -1.010
Jun '19 0.00 -1.541
Mar '19 92.36 -0.835
FY 2018 Dec '18 0.00 -2.144
Sep '18 0.00 -2.134
Jun '18 0.00 -2.233
Mar '18 0.00 -1.959
 
*Note: Units in Millions ofTaiwanese Dollars
**Note: Units in Taiwanese Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 36.66 39.18
P/E High - Last 5 Yrs. -- 43.25 46.36
P/E Low - Last 5 Yrs. -- 25.37 25.32
Beta -- 0.93 0.91
Price to Sales (TTM) -- 4.70 9.80
Price to Book (MRQ) -- 4.64 5.01
Price to Tangible Book (MRQ) -- 6.31 6.98
Price to Cash Flow (TTM) -- 19.76 28.08
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.46
Dividend Yield - 5 Year Avg -- 0.94 0.93
Dividend 5 Year Growth Rate -- 4.34 5.10
Payout Ratio(TTM) -- 52.64 49.18

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 17.42 15.38
Sales (TTM) vs TTM 1 Yr. Ago -100.00 18.09 16.85
Sales - 5 Yr. Growth Rate -- 5.88 6.15
EPS (MRQ) vs Qtr. 1 Yr. Ago 41.92 5.76 -6.22
EPS (TTM) vs TTM 1 Yr. Ago -14.55 -- --
EPS - 5 Yr. Growth Rate -- 8.81 9.02
Capital Spending - 5 Yr. Growth Rate -- 13.14 13.04

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.66 2.63
Current Ratio (MRQ) 4.47 3.67 3.62
LT Debt to Equity (MRQ) -- 12.54 14.71
Total Debt to Equity (MRQ) -- 17.08 19.76
Interest Coverage (TTM) -742.28 7.97 11.73

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.26 55.04
Gross Margin - 5 Yr. Avg. -- 54.97 54.49
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -825.05 19.35 12.80
Operating Margin (TTM) -- 14.83 -8.62
Operating Margin - 5 Yr. Avg. -984.76 15.05 7.89
Pre-Tax Margin (TTM) -- 15.16 -9.80
Pre-Tax Margin - 5 Yr. Avg. -1,001.63 15.33 8.07
Net Profit Margin (TTM) -- 11.37 -13.57
Net Profit Margin - 5 Yr. Avg. -1,004.43 11.61 4.47
Effective Tax Rate (TTM) -- 22.67 22.84
Effective Tax Rate - 5 Yr. Avg. -- 22.22 22.31

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 938,038,196 813,824,799
Net Income/Employee (TTM) -- 104,262,187 90,388,774
Receivable Turnover (TTM) -- 5.35 6.29
Inventory Turnover (TTM) -- 2.72 3.64
Asset Turnover (TTM) 0.00 0.86 0.84

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -142.20 10.84 10.23
Return on Assets - 5 Yr. Avg. -75.22 11.08 10.62
Return on Investment (TTM) -170.25 13.40 12.82
Return on Investment - 5 Yr. Avg. -85.28 13.85 13.28
Return on Equity (TTM) -422.38 14.84 14.41
Return on Equity - 5 Yr. Avg. -279.76 16.79 16.15
  1 Year 3 Year 5 Year
Sales % -- -37.21 --
EPS (TTM) % -5.24 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aslan Pharmaceuticals Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -20.31 -23.19 9 71
13 Week 31.77 6.92 57 47
26 Week -37.53 -36.48 13 81
52 Week -74.95 -77.33 11 86
YTD -37.53 -37.07 12 81
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.12%
# of Holders: 1
Total Shares Held: 228,000
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.